BPTF and non-small cell lung carcinoma: BI-2536 and bromosporine are the first two discovered inhibitors of BPTF, but their specificity are limited.526,527 Zhang et al. screened out a selective BPTF bromodomain inhibitor, called DCB29, but the biological function is unknown.528 Xu et al. identified another BPTF bromodomain inhibitor, named C620-0696, which suppressed the progression of NSCLC mainly by inhibiting c-Myc transcription.529